2 results
Approved WMOCompleted
To validate the use of the Livv Mobiel ECG as a reliable office/bedside screening tool in primary care practice
Approved WMOCompleted
PHASE IIPrimary ObjectiveThe primary objective of the Phase II portion of the study is to estimate the efficacy as measured by radiographic progression-free survival of IPATASERTIB (GDC-0068) (dosed at either 400 mg or 200 mg daily) + abiraterone…